Kissei Pharmaceutical Co., Ltd.

Toshihide Shibazaki

Masayuki Isaji

Nobuhiko Fushimi

Kazuo Shimizu

Shigeru Yonekubo

Hirotaka Teranishi

The present invention provides pyrazole derivatives represented by the general formula: wherein Rrepresents H, an optionally substituted Calkyl group etc.; one of Q and T represents a group represented by the general formula: or a group represented by the general formula: while the other represents an optionally substituted Calkyl group etc.; Rrepresents H, a halogen atom, OH, an optionally substituted Calkyl group etc.; X represents a single bond, O or S; Y represents a single bond, a Calkylene group etc.; Z represents CO or SO; Rand Rrepresent H, an optionally substituted Calkyl group etc.; and R, Rand Rrepresent H, a halogen atom etc., pharmaceutically acceptable salts thereof or prodrugs thereof, which exhibit an excellent inhibitory activity in human SGLT1 and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complications or obesity, and pharmaceutical compositions comprising the same, pharmaceutical uses thereof, and intermediates for production thereof.

Growing community of inventors

Nagano, Japan

Toshihide Shibazaki